Description
Recombinant monoclonal antibody to CA 19-9. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 1116-NS-19-9. This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
CA 19-9
Target Alias Names
CD43, Colorectal carcinoma, CA19-9, sialyl Lewis A, sLe A, 1116-56-2, 1116NS19.9, 1116-NS-19–9
Isotype/Mimetic
IgG
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression